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Missense, nonsense, and frameshift mutations in the human
anion exchanger 1 have been associated with inherited distal
renal tubular acidosis and hereditary spherocytosis. These
two disorders, however, are almost always mutually
exclusive. We have found an important and unusual
exception: a novel combination of heterozygous E522K and
G701D mutations in the anion exchanger 1 manifested as
complete distal renal tubular acidosis and severe hereditary
spherocytosis in an affected patient. Analysis of protein
trafficking and subcellular localization of the wild-type kidney
isoform of human anion exchanger 1 and these mutants
transfected into MDCK cells showed they formed
homodimers or heterodimers with each other. Homodimers
of the wild-type and E522K mutant were found at the plasma
membrane, whereas the G701D mutant largely remained in
the cytoplasm. Heterodimers of either E522K or G701D and
the wild-type exchanger were located in the plasma
membrane, whereas E522K/G701D heterodimers remained in
the cytoplasm. Our study shows that the compound E522K/
G701D mutation of human anion exchanger 1 causes a
trafficking defect in kidney cells, and this may explain the
complete distal renal tubular acidosis of the patient.
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Erythroid anion exchanger 1 (eAE1), also known as band 3, is
one of the most abundant proteins in the red blood cell
membrane.1–4 The AE1 gene is a member of the bicarbonate-
anion transporters of the SLC4 gene family.5 The central
transmembrane domain performs anion exchange in ery-
throcyte and kidney cells. The erythroid isoform of AE1
(eAE1) is expressed in the red blood cells. The truncated
kidney isoform of AE1 (kAE1) is missing the N-terminal 65
amino acids and, beginning at Met-66, is expressed in renal
tubular a-intercalated cells.
Missense, nonsense, and frameshift mutations are liable to
occur anywhere in the coding sequences of the AE1 gene in
hereditary spherocytosis (HS) patients.1–4 However, AE1
mutations, which affect the central transmembrane domain
and the short C-terminal tail, are also associated with
inherited distal renal tubular acidosis (dRTA), clinically
classified as ‘complete and incomplete forms’, based on the
presence or absence of spontaneous metabolic acidosis.6–8
The AE1 G701D mutation is responsible for Southeast Asian
recessive dRTA.9–15 Combined anemia (not HS) and dRTA in
the setting of several instances of compound heterozygosity
for AE1 mutations have been reported.12 Very few patients
with HS attributable to AE1 (band 3) mutations are
associated with dRTA, and the same applies vice versa,1–3,8–25
so that HS and dRTA are almost always mutually exclu-
sive.2,8,25 To the best of our knowledge, the first human
exception is a patient in whom AE1 was totally absent, and
who presented with complete dRTA and severe HS because of
a band 3 Coimbra (V488M) in the homozygous state.26 An
acid loading test revealed that HS patients with band 3
Pribram (C-terminally truncated AE1 protein) or Courcour-
onnes (S667F) have incomplete dRTA.27,28 Knockout animal
models were developed and reported on in 1996.29–31
Knockout cattle and mice in which AE1 was totally absent
had marked spherocytosis and metabolic acidosis.29,30,32
Here, the second human exception (not incomplete
dRTA), because of a novel heterozygous E522K mutation
(band 3 Kaohsiung) in combination with a heterozygous
G701D mutation, exhibited complete dRTA and severe HS.
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We investigated the molecular mechanism that causes
complete dRTA because of these mutations.
RESULTS
Clinical features
In September 2003, a 7-month-old boy was admitted because he
looked extremely pale. His red blood cell indices were as follows:
hemoglobin, 4.6 g per 100 ml; mean corpuscular volume, 94 fl;
and mean corpuscular hemoglobin concentration, 30.5 g per
100 ml (Table 1). A peripheral blood smear showed marked
anisocytosis and spherocytosis, which are typically represented
by small, dark-stained red cells without a central pallor
(Figure 1a). The reticulocytes accounted for 8.4% of the total
red blood cells on the smear (Table 1). An osmotic fragility test
yielded an abnormal finding. Arterial blood gas analysis revealed
pH 7.02, plasma HCO3 4.9 mEq/l, and base excess
23.1 mEq/l. Serum biochemistry showed total bilirubin at
3.7 mg per 100 ml, Naþ at 138 mmol/l, Kþ at 3.2 mmol/l, and
Cl at 125 mmol/l. After the child had been given sodium
bicarbonate supplements for 1 day, we used an arterial blood gas
test (pH 7.22, HCO3 9.4 mEq/l), which confirmed complete
dRTA with inappropriately high urine pH (UpH 7.78) using the
diagnostic criteria of urinary pH over 6.0 despite systemic
acidosis. Urine anion gap was þ 15 mmol/l. Fractional excretion
of bicarbonate and urine to blood (U-B) pCO2 showed normal
findings. This patient was diagnosed with complete dRTA and
severe HS, which responded reasonably well to the treatment
with daily sodium bicarbonate supplements (6.5 mEq/kg daily)
and regular blood transfusions. He had severe splenomegaly, but
no nephrocalcinosis or bone disease.
His parents and brother had no anemia, splenomegaly, or
renal or bone disease. Both parents and the brother were of
normal stature and had normal plasma bicarbonate values
(Table 1). The patient’s brother and mother had normal
bicarbonate reabsorption and renal acidification function
according to their fractional excretion of bicarbonate, urine to
blood (U-B) pCO2, urinary anion gap, and ammonium chloride
loading tests. His mother and brother had few spherocytes on
peripheral blood smears (Figure 1b). Both his brother and
mother had very mild HS, according to the guidelines.4
Profiling red blood cell membrane protein
To investigate whether the membrane protein defect is
associated with the phenotype of HS, we analyzed red cell
membrane protein profiles with sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and Coo-
massie blue staining. The patient’s eAE1 protein level was
only 23% of that in normal controls (N1–N4) (Figure 1c).
This result indicated that a low level of eAE1 protein may be
associated with the phenotype of HS and dRTA, which is
supported by missense, nonsense, and frameshift mutations
of AE1 tightly associated with HS and dRTA.1–4,8–25
Detecting AE1 mutations in genomic DNA
To investigate whether mutations of the AE1 gene were
responsible for the clinical manifestations, we analyzed
genomic DNA sequencing. Our results revealed four point
mutations in the patient (92 T4C, 166 A4G, 1564 G4A,
2102 G4A, numbered from the eAE1 mRNA translation
Table 1 | Laboratory studies and genotypes
Hb, grams per 100ml MCHC, grams per 100ml Bil, miligrams per 100ml Reticulocyte Spherocytes Acidosis Genotype
Patient 4.6 30.5 3.7 8.4% Many + E522K/G701D
Brother 11.5 35 2 2% Few  E522K/WT
Father 15.7 33.7 0.8 1% Nil  G701D/WT
Mother 12.1 35.6 2.6 1.8% Few  E522K/WT
Bil, bilirubin; Hb, hemoglobin; MCHC, mean corpuscular hemoglobin concentration; Normal blood pH: 7.35–7.45.
eAE1
Spectrin
N1 N2 N3 N4 Patient Brother Father Mother
Figure 1 |Red blood cell morphology and sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of red
blood cell membrane proteins. (a) Peripheral blood smear of
the patient shows spherocytosis (arrows) and anisocytosis. (b)
Peripheral blood smear of the mother shows two spherocytes
(arrows). (c) SDS-PAGE-separated, Coomassie blue-stained red
blood cell ghost polypeptides prepared from intact red blood
cells. N1–N4, four normal controls. Spectrin is the internal control
to standardize the loading amount.
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start codon) changing a methionine (ATG) in codon 31 to
threonine (ACG), a lysine (AAG) in codon 56 to glutamic
acid (GAG), a glutamic acid (GAG) in codon 522 to lysine
(AAG), and a glycine (GGC) in codon 701 to aspartic acid
(GAC) (Figure 2a and b). The mutations M31T, K56E, and
G701D were found in the patient’s asymptomatic father,
which suggested that this is whence these mutations came,
whereas the E522K (band 3 Kaohsiung) mutant was found in
his mother and brother, which indicated this mutation had a
maternal origin (Figure 2b). Figure 3a illustrates the four
mutations of the patient into the proposed topographic
models of human eAE1 polypeptide,3,8,9 and the E522K
mutation located near the intracellular boundary of the
transmembrane segment TM5. Human kidney AE1 (kAE1),
which begins at Met 66,2,8 lacks codons 31 and 56.
Glutamic acid 522 in AE1 protein is highly conserved in nine
mammalian species
Comparing the primary structures of the SLC4A family from
nine species showed that glutamic acid 522 and glycine 701
were highly conserved across all nine species (Figure 3b).
Constructing the DNA of kAE1 and its mutants
PCR, as described in Methods, was used to construct human
kAE1 and its mutants. Madin-Darby canine kidney (MDCK)
cells, which do not express endogenous AE1 and have been
used in AE1 trafficking studies,33–35 were transiently trans-
fected with plasmids to express HA-tagged kAE1 WT, kAE1
E522K, and kAE1 G701D proteins in this study (Figure 4a).
G701D mutants were retained in cytoplasm, but WT and
E522K mutants reached the plasma membrane in MDCK cells
Immunofluorescence experiments were done to investigate
the subcellular localization of kAE1 E522K and kAE1G701D
mutants. Confocal images of transfected MDCK cells showed
that HA-tagged kAE1 WT and kAE1 E522K reached the
plasma membrane. The membrane localization of kAE1 was
confirmed using co-localization with E-cadherin, a basolat-
eral membrane marker (Figure 4b).35 Moreover, the partial
co-localization of the kAE1 WT (or kAE1 E522K) and
DsRed-ER, an endoplasmic reticulum (ER) marker,36 in-
dicated that a certain portion of kAE1 was localized in ER
(Figure 4c). However, HA-tagged kAE1 G701D showed no
co-localization with E-cadherin in transfected MDCK cells,
which suggested that the mutant protein was not present in
the plasma membrane (Figure 4b). The kAE1 G701D was
partially localized to ER (Figure 4c), which is supported by a
report that kAE1 G701D co-localized with the ER marker
calnexin and Golgi marker giantin in MDCK cells.35
To determine the presence or absence of wild-type
basolateral targeting as a property of kAE1 E522K, transiently
transfected MDCK cells were examined on filter supports as
polarized cells. Similar to kAE1 WT, kAE1 E522K was found
at the basolateral membrane after cellular polarization
(Figure 4d). By contrast, kAE1 G701D was retained
intracellularly in polarized cells. Taken together, the results
confirmed that G701D mutants were retained in the
cytoplasm, whereas the WT and E522K mutants reached
the basolateral membrane in MDCK cells. Two possible
mechanisms that might have caused AE1 mutants to be
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Figure 2 |DNA sequence profiles and family pedigree.
(a) Identifying the AE1 (band 3) mutations. DNA sequence profiles
of the regions adjacent to codons 522 and 701 for the father (I:1),
the mother (I:2), the brother (II:1), and the patient (II:2). In the
patient and his mother and brother, the band 3 Kaohsiung
(E522K) substitutes glutamic acid (GAG) in codon 522 for lysine
(AAG). In the patient and his father, the band 3 Bangkok I (G701D)
changes glycine (GGC) in codon 701 to aspartic acid (GAC).
(b) Family pedigree. Allele band 3 Kaohsiung is indicated by cross
hatching, allele band 3 Bangkok I by horizontal symbols.
776 Kidney International (2009) 76, 774–783
or ig ina l a r t i c l e Y-H Chang et al.: Compound AE1 mutations associated with dRTA and HS
retained in the cytoplasm are AE1 protein misfolding that
prevented their dimerization or their moving to the cell
surface, which increases the degradation and consequently
the functional loss of AE1.8,9,15,33–35
The WT formed heterodimers with the E522K and G701D
mutants, which helped them reach the cell surface
To clarify which mechanism caused these two mutants to be
retained in the cytoplasm, co-immunoprecipitation was used
to examine the co-expression of HA-tagged and flag-tagged
AE1 constructs in the interactions between kAE1 WT, kAE1
E522K, and kAE1 G701D. Cell lysates were first immuno-
precipitated with anti-HA antibody and the precipitates were
analyzed using immunoblotting with anti-flag antibody.
Heterodimers formed between flag-kAE1 WT and HA-kAE1
WT, flag-kAE1 WT and HA-kAE1 E522K, and flag-kAE1 WT
and HA-kAE1 G701D (Figure 5). This was supported by the
co-localization of flag-kAE1 WT and HA-kAE1 mutants
(Figure 6a). On the basis of the quantitative analysis
described in Methods and Figure 6b, co-expression of flag-
kAE1 WT and HA-kAE1 WT showed that the cell peripheral
expression for both tagged proteins was about 42.2±14.7%
for HA-tagged WT and 46.8±14.8% for flag-tagged WT
(n¼ 10) (Figure 6c). Similarly, co-expression of flag-kAE1
WT and HA-kAE1 E522K or HA-kAE1 G701D revealed
obvious cell peripheral co-expression and co-localization
of kAE1 proteins (Figure 6a). The cell peripheral expres-
sion showed no significant difference (P40.05) between
co-expression of WT/WT and E522K/WT or G701D/WT
(Figure 6c).
Intact KAE1 WT/WT cells were biotinylated with NHS-
SS-biotin to investigate the cell surface expression of kAE1 in
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Figure 3 | Schematic model and sequence comparisons. (a) Schematic model of eAE1. Codon substitutions encoded by the four
mutations detected in the indicated exons of the AE1 gene are mapped into a topographic representation of human eAE1 polypeptide
modified by Tanphaichitr et al.9 The Band 3 Kaohsiung mutation (AE1 E522K) causes a substitution of a glutamic acid in the intracellular
boundary of the transmembrane segment TM5. The two transmembrane domains with E522K and G701D mutations are within the region
of less certain topography. (b) Sequence comparisons for eAE1 (band 3, SLC4A1, P02730) and related anion exchanger proteins. The codon
AE1 522 glutamic acid was conserved in the 31 related proteins (rectangle), which were retrieved from the UniProtKB/Swiss-Prot database
(http://www.expasy.org) and aligned using the program ClustalW (http://www.ebi.ac.uk/clustalw/). The primary accession numbers and
entry names used in the UniProtKB/Swiss-Prot database are in the first column. The SLC4 family numbers are in the second column, and the
amino acid sequences of the 31 proteins are in the third column. *Conserved amino acids.
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co-transfected MDCK cells (Figure 7, lane B). This indicated
the presence of kAE1 at the cell surface, which was
determined to be 41.7±5.3% (n¼ 3±s.d.) of the total
kAE1 expression. However, the percentage of the total kAE1
protein on the cell surface was 51±6%, determined by cell
surface biotinylation in stably transduced non-polarized
MDCK cells.33 The difference in percentages of WT kAE1
at the cell surfaces of transiently and stably transfected
MDCK cells might have been because the expression level is
usually very high in a transient transfection assay, which
overloads the folding and assembling capacity of ER and
Golgi complex.37
Similarly, co-expression of WT and E522K or G701D
revealed obvious cell surface expression of kAE1 proteins
(Figure 7). The cell surface expression was not significantly
different (P40.05) from the co-expression of WT/WT and
E522K/WT or G701D/WT. These results indicated that kAE1
WT prevented the intracellular retention of kAE1 G701D,
which allowed the mutant protein to move from the ER to
the plasma membrane through hetero-oligomerization. The
above results not only defined the recessive characteristic of
these two mutations, but also explained the normal
phenotype of the patient’s father and mother.
E522K formed a homodimer and moved to the cell surface
Co-immunoprecipitation was also used to investigate the
formation of the E522K homodimer. Flag-tagged kAE1
E522K was detected in an anti-HA antibody immunopreci-
pitated complex that co-expressed HA-tagged kAE1 E522K
and flag-tagged kAE1 E522K (Figure 5, lane 5), which showed
that a homodimer of E522K had been formed. Furthermore,
co-expression of flag-kAE1 E522K with HA-kAE1 E522K in
MDCK cells showed peripheral expression of 31.1±9.7%
(n¼ 10) (Figure 6a and c, anti-HA). These results were
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Figure 4 | Expression and cellular localization of wild-type and mutant kAE1 fusion proteins in MDCK cells. (a) Cells transiently
transfected with mock, pcDNA3.1 vector, HA-kAE1 WT, HA-kAE1 E522K, and HA-kAE1 G701D. The cell lysates were immunoblotted with anti-
HA antibody. (b) Cellular localization of kAE1, kAE1 E522K, kAE1 G701D, and E-cadherin. Transfected MDCK cells expressing either
HA-tagged kAE1 WT, E522K, or G701D were grown on glass coverslips, fixed, permeabilized, and incubated with mouse anti-HA and rabbit
anti-E-cadherin antibody. After the cells were washed, they were incubated with goat anti-mouse FITC and goat anti-rabbit rhodamine, used
to visualize kAE1 and E-cadherin, respectively. After they had been stained with DAPI, the localization of fluorescently labeled proteins was
visualized, using a confocal microscope. E-cadherin is a basolateral membrane marker. (c) Cellular localization of kAE1, kAE1 E522K, kAE1
G701D, and DsRed/ER. Transfected MDCK cells expressing DsRed/ER and either HA-tagged kAE1 WT, E522K, or G701D were grown on glass
coverslips. The cells were then fixed, permeabilized, and incubated with mouse anti-HA antibody. After they were washed, the cells were
stained with DAPI and goat anti-mouse antibody bound to FITC. The kAE1 proteins were then observed, using a confocal microscope. The
endoplasmic reticulum was visualized with DsRed-ER localization vector. (d) Cellular localization of kAE1 and mutants in polarized MDCK
cells. Transiently transfected MDCK cells expressing kAE1 WT, E522K, or G701D, grown on polycarbonate filters, were detected using anti-HA
antibody (green), whereas basolateral membrane was marked with E-cadherin (red) and nucleus was stained with DAPI (blue). Yellow
staining corresponds to overlap between green and red labeling. X–Y shows middle section of the cells. X–Z corresponds to side view of the
cells. Anti-E-cad, anti-E-cadherin antibody; Anti-HA, anti-HA antibody. Bar represents 10 mm. Results shown are typical of three independent
experiments.
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significantly (*P¼ 0.032) lower compared with peripheral
expression (42.2±14.7%) (n¼ 10) of WT homodimer
(Figure 6c). Similarly, peripheral expression of E522K was
mildly lower (Figure 4c). In the biotinylation experiment,
E522K homodimer cell-surface expression (20.3±6.2%)
(n¼ 3) was significantly lower (*P¼ 0.011) compared with
WT homodimer expression (41.7±5.3%) (n¼ 3) (Figure 7).
E522K mutant formed heterodimer with G701D mutant but
did not help it reach the cell surface
Lysates from MDCK cells co-expressing either HA-kAE1
G701D/flag-kAE1 G701D or HA-kAE1 G701D/flag-kAE1
E522K were immunoprecipitated using anti-HA antibody,
and then immunoblotted using anti-flag antibody. kAE1
G701D/G701D and kAE1 E522K/G701D heterodimers were
formed (Figure 5, lanes 6–7). Co-expressed HA-kAE1 G701D
with either flag-kAE1 G701D or flag-kAE1 E522K revealed
obvious intracellular retention and co-localization of both
mutant kAE1 proteins (Figure 6a), with average percentages
of relative cell peripheral expression of 0 and 0% (n¼ 10),
respectively (Figure 6c, anti-HA). Cell peripheral localization
of these mutant proteins was significantly (Po0.0001) lower
compared with co-expressed flag-kAE1 WT with HA-kAE1
WT. Taken together, all these results suggested that 100% of
the kAE1 G701D/G701D and E522K/G701D mutant proteins
were retained in the cytoplasm. Moreover, in the cell-surface
biotinylation experiment, the kAE1 G701D mutant was not
detected in the biotinylated fraction in MDCK cells co-
transfected with kAE1 G701D/G710D and G701D/E522K
(0.5±0.4% and 0.3±0.3%, respectively, n¼ 3) (Figure 7,
lane B). The results indicated that kAE1 E522K and kAE1
G701D did not help each other move to the cell surface,
which resulted in their intracellular retention; this helps
explain the dRTA phenotype of the patient. Similarly, the
intracellular retention of kAE1 G701D/G701D mutant
protein was consistent with other trafficking studies.9,15,35
The kAE1 E522K and G701D mutations destabilized
themselves
To clarify whether retaining kAE1 mutants in the cytoplasm
destabilizes themselves, the protein expression levels and
stability were monitored at 0, 4, 7, and 11 h after treating cells
with cycloheximide, a protein biogenesis inhibitor (Figure
8a). At 0 h, the level of kAE1 mutant proteins were lower than
that of kAE1 WT (Figure 8a), and the expression levels of
kAE1 WT and kAE1 mutants (kAE1/actin ratios) were set at
100% (Figure 8b). The immunoblotting showed that more
rapid reduction in kAE1 E522K and G701D expression than
in kAE1 WT was most likely caused by a more rapid turnover
of kAE1 mutants (Figure 8a and b). In these experiments, the
half-life of both kAE1 WT and kAE1 E522K was about 11 h,
whereas the half-life of kAE1 G701D was about 5 h (Figure
8b). These results were similar to reports that kAE1 S773P
and kAE1 SAO have a half-life of about 5 h in human
embryonic kidney cells (HEK 293 cells),15,38 and that kAE1
G701D has a half-life of about 6 h in MDCK cells.35
Misfolded mutant proteins did not reach the cell surface,
and then the cellular quality control system degraded the
mutants.39,40 ER- and lysosome-associated degradation
may explain the 5-h half-life of the G701D mutant and
its retention in ER (Figure 4c) and co-localization
with lysosomes (results not shown); this agrees with a
report that proteosome- and lysosome-dependent degraded
E258K aquaporin-2 caused congenital nephrogenic diabetes
insipidus.41
DISCUSSION
The patient in this study is the second human being with
complete dRTA and severe HS because of a novel hetero-
zygous E522K mutation (band 3 Kaohsiung) combined with
a heterozygous G701D mutation. The band 3 Kaohsiung
mutation may cause the substitution of a glutamic acid in the
intracellular boundary of the fifth transmembrane segment
(TM5) (Figure 3a). The substitution replaces glutamic acid, a
negatively charged hydrophilic amino acid, with lysine, a
positively charged hydrophilic residue. In addition to
hydrophobic segments, the distribution of positively charged
amino acids seems to be an important determinant in
eukaryotic membrane topology.42
The recessive dRTA mutants, such as homodimer S773P
and DV850, are impaired when they shift to the plasma
membrane and localize to the ER in non-polarized and
polarized MDCK cells, respectively. Similarly, the other
recessive mutant, kAE1 G701D, localized to the ER and
Golgi marker in both non-polarized and polarized cells.35,43
However, this study revealed that the novel homodimer kAE1
E522K also moved to the plasma membrane (Figures 4b, d, 6a
and 7). The effect of the novel missense recessive mutation
E522K on the biosynthesis of kAE1 was characterized in
pcDNA3.1 +
+
+
++
+ + +
+
IP:anti-HA
IB:anti-Flag
+
+
+++
pcMV
HA-kAE1 WT
HA-kAE1 E522K
HA-kAE1 G701D
Flag-kAE1 WT
Flag-kAE1 E522K
Flag-kAE1 G701D
95 kDa
95 kDa
Figure 5 |Co-immunoprecipitation and immunoblotting.
MDCK cells co-transfected with differentially tagged proteins
(HA- or flag-) were lysed. The cell lysates were incubated with
mouse anti-HA monoclonal antibody and agarose ligand. The
bound proteins were eluted with denatured buffer, and HA-
tagged proteins were detected using immunoblotting with
mouse anti-HA monoclonal antibody (IP) or rabbit anti-flag
polyclonal antibody (IB). After the membranes were washed, they
were incubated with HRP-conjugated second antibodies. IP,
immunoprecipitation; IB, immunoblotting. Results shown are
typical of three independent experiments.
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experiments of co-transfected MDCK cells; they revealed
that the kAE1 E522K mutants formed homo-oligomers
and less efficiently moved to the plasma surface (Figures 5,
6c and 7).
The kAE1 E522K/WT heterodimer moved to the plasma
membrane, but the kAE1 E522K mutant did not reach the
cell surface in the presence of kAE1 G701D (Figures 6a and
7). These would explain the normal phenotype of the mother
with the genotype of kAE1 WT/E522K and the dRTA
phenotype of the patient with kAE1 E522K/G701D. kAE1
WT protein helped the mutant kAE1 G701D reach the cell
surface, but kAE1 E522K did not help it reach the plasma
membrane, which is similar to the reports that kAE1 SAO
and kAE1 S773P formed heterodimers with kAE1 G701D
but did not help it reach the plasma membrane.15,44 Taking
all these findings together, we conclude that kAE1
WT protein forms heterodimers with kAE1 E522K, G701D,
SAO, and S773P mutants and helps them reach the cell
surface.15,44
In conclusion, HS and dRTA are almost always mutually
exclusive.2,8,25 However, our patient was the second known
human being with complete dRTA and severe HS, a
comorbidity caused, in this case, by the synergistic effects
of a symptomless band 3 Bangkok I allele and a novel band 3
Kaohsiung allele that generated only slight HS with a band 3
deficiency.
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Figure 6 |Co-localization of kAE1 E522K, kAE1 G701D, and wild-type AE1 at the plasma membrane. (a) Non-polarized MDCK cells
transiently co-transfected with six combinations: kAE1 WT/WT, E522K/WT, G701D/WT, E522K/E522K, G701D/G701D, and G701D/E522K. At 1
day after co-transfection, the cells were fixed with 3.7% paraformaldehyde, permeabilized using incubation in 0.4% Triton X-100, blocked
with 2% goat serum, and then stained with mouse anti-HA monoclonal and rabbit anti-flag polyclonal antibodies that recognize HA-kAE1
and flag-kAE1, respectively. After the cells were washed, they were incubated with goat anti-mouse FITC and goat anti-rabbit rhodamine to
visualize kAE1 and E-cadherin, respectively. After the cells were stained with DAPI, the localization of fluorescently labeled proteins was
visualized using a confocal microscope. Anti-HA, anti-HA antibody; Anti-flag, anti-flag antibody. Bar represents 10 mm. Results shown are
typical of three independent experiments. (b) Quantitative procedure. Top panel: the intensity of kAE1 immunofluorescence of the area of
the entire cell (area I) was measured in the AE1-transfected MDCK cells. Middle panel: the intensity of kAE1 immunofluorescence of the area
within the bounds of the line just inside the membrane (area II) was measured. Lower panel: the difference between the values from area I
and area II represents the peripheral kAE1. (c) Quantitative analysis for immunofluorescence imaging. The bar graph shows the percentage
of peripheral co-expression of kAE1 WT/WT, E522K/WT, G701D/WT, E522K/E522K, G701D/G701D, and G701D/E522K from MDCK cells. The
immunofluorescence image was analyzed using NIH image software. Error bars represent s.d. (n¼ 10). *, ** significant decreases compared
with WT/WT (Po0.05 and Po0.01, respectively; two-tailed unpaired Student’s t-tests).
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MATERIALS AND METHODS
Erythrocyte membrane protein analysis
The erythrocyte ghosts were prepared using methods previously
described.45 Red blood cell membrane proteins were analyzed using
Coomassie blue-stained 10% SDS-PAGE.46 Image analysis software
(NIH Image; Wayne Rasband, National Institutes of Health,
Bethesda, MD, USA) was used for densitometric measurement to
quantify the protein content of red cell membrane proteins.46,47
AE1 genomic DNA analysis
Using Genomic DNA as templates, all exons of the AE1 gene were
amplified using PCR with pairs of intronic primers flanking the
exons. The primers were designed based on a previously described
method.18
Sequence comparisons for AE1 (SLC4A1) and related proteins
Amino acid sequences of all 31 currently known sequences of
SLC4A1, SLC4A2, SLC4A3, SLC4A4, SLC4A5, SLC4A7, SLC4A8,
SLC4A9, and SLC4A10 from humans and mammals were retrieved
from UniProt/TrEMBL (http://www.expasy.org) and aligned using
the ClustalW program (http://www.ebi.ac.uk/clustalw/).
Constructing WT full-length cDNA and mutants
Full-length cDNA was constructed as previously described.47. Total
RNA was isolated from the buffy coat of the patient’s blood using
acidic guanidinium isothiocyanate TRI-reagent (Invitrogen,
Carlsbad, CA, USA). Extracted RNA was reverse-transcribed into
cDNA using a kit (ImProm-II Reverse Transcription System;
Promega, Madison, WI, USA) according to the manufacturer’s
instructions. Using cDNA as template, four fragments were
amplified by PCR using the four primers (1) kAE1 RsrII-F: 50-
GACACGGTCCGATGGACGAAAGAACCAG-30 (RsrII site and
196–212, start codon of the kidney isoform); (2) D: 50-TCCGA-
CACTCCCATCTGGTT-30 (1316–1297); (3) E: 50-AGACTC-
CAGCTTCTACAAGG-30 (1062–1081); and (4) RsrII-R: 50-
GACACGACCGTCACACGGCATGGCCACT-30 (RsrII site and
2719–2736). The PCR products were separated, purified, and ligated
into the yT&A vectors. The yT&A vectors were sequenced and
subcloned into the pcDNA3.1-HA-CPO and pCMV2.0-flag-CPO
(modified by adding an RsrII restriction enzyme site) (Invitrogen),
thus yielding six plasmid constructs expressing kAE1, kAE1 E522K,
and kAE1 G701D fused with either HA or flag tag at its N-terminus.
Cell culture and transient transfection
Madin-Darby canine kidney cells were maintained in DMEM with
10% cow bovine serum, 2 mM of L-glutamine, 100 U/ml of
penicillin, and 100mg/ml of streptomycin at 37 1C in 5% CO2.
The plasmids were transiently transfected using a reagent (Lipo-
fectamine; Invitrogen).47 Polarized MDCK cells were obtained by
growing confluent cells on Transwell polycarbonate filters (Corning
Headquarters, Corning, NY, USA) for 4–5 days.
Immunoblotting analysis
Proteins were separated using 10% SDS-PAGE and then transferred
to a PVDF membrane, which was incubated with rabbit anti-flag
antibody (Santa Cruz Biotechnology, Inc, Santa Cruz, CA, USA) or
Vector
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38.4 ± 15.4 20.3 ± 6.2* 0.5 ± 0.4** 0.3 ± 0.3**
33.8 ± 4.3
U B T U B T U B T U B
T U BT U BT U BT U B
No biotin WT/WT E522K/WT
Figure 7 | Surface biotinylation on MDCK cells co-transfected
with combinations of kAE1 WT, E522K, and G701D.
Transfected MDCK cells were surface-biotinylated by incubating
them twice with NHS-SS-biotin reagent in borate buffer. The cells
were quenched of any unreacted reagent, and the biotinylated
proteins in the cell lysates were captured using
streptavidin–agarose beads. Immunoblotting with anti-HA
antibody showed the amount of kAE1 in the total (lane T),
unbound to streptavidin beads (lane U) and bound to streptavidin
beads (lane B). The percentage of the cell surface expression was
quantitated by scanning lanes T and B and analyzing the images
with NIH image software (n¼ 3). *, ** significant decreases
compared with WT/WT *, ** significant decreases compared with
WT/WT. (Po0.05 and Po0.01, respectively; two-tailed unpaired
Student’s t-tests).
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Figure 8 |Protein stability experiments with kAE1 WT, kAE1
E522K, and kAE1 G701D. (a) The transfected MDCK cells
expressing HA-kAE1 WT, HA-kAE1 E522K, or HA-kAE1 G701D grew
on 12-well tissue culture plates for 24 h. At each time checkpoint,
0, 4, 7, and 11 h after cycloheximide (a protein biogenesis
inhibitor) was added, the cell lysates were immunoblotted with
anti-HA and anti-actin antibodies (an internal control). (b) The
results of quantitative densitometric scanning and analysis using
NIH software are shown in the graph. Each data point is the mean
derived from four measurements at each time point. Error bars
represent the s.d. (n¼ 4).
Kidney International (2009) 76, 774–783 781
Y-H Chang et al.: Compound AE1 mutations associated with dRTA and HS o r ig ina l a r t i c l e
mouse anti-HA monoclonal antibody (Santa Cruz Biotechnology).
After it had been washed, the membrane was incubated with HRP-
conjugated second antibody. Immunoreactivity was detected using
an ECL chemiluminescence kit (Amersham Biosciences, Piscataway,
NJ, USA).
Immunofluorescence analysis
MDCK cells,48 transfected with DsRed-ER (Clontech, BD Bios-
ciences, Palo Alto, CA, USA) and either plasmids expressing kAE1
WT, E522K, or G701D fused HA epitope, were left to grow on cover
slips or Transwell polycarbonate filters, fixed with 3.7% parafor-
maldehyde in PBS or 100% methanol, permeabilized by incubating
them in 0.4% Triton X-100, and blocked with 2% goat serum for
15 min. The cells were then incubated with the mouse anti-HA
monoclonal antibody (Santa Cruz Biotechnology), and E-cadherin
antibody (Transduction Laboratories, Lexington, KY, USA) at 4 1C
overnight. After they had been washed, the cells were incubated
with secondary antibody. After the cells had been stained with DAPI,
the localization of fluorescently labeled proteins was visualized using
a confocal microscope (LSM 510; Carl Zeiss MicroImaging,
Thornwood, NY, USA).
Co-immunoprecipitation
MDCK cells (co-transfected with plasmids expressing WT/WT, WT/
E522K, WT/G701D, E522K/E522K, G701D/G701D, E522K/G701D
fused with flag and HA epitope) were homogenized in RIPA
lysis buffer.49,50. The supernatant was incubated with 10ml of
mouse anti-HA monoclonal antibody and agarose ligand
(Millipore, Billerica, MA, USA) and rotated in a cold room
overnight. After they had been washed thrice, the proteins were
eluted with 1 denaturizing buffer. Protein lysate (40 mg) was
analyzed using SDS-PAGE and then transferred to a PVDF
membrane, which was then analyzed using immunoblotting as
described above.
Co-localization
MDCK cells (co-transfected with plasmids expressing WT/WT, WT/
E522K, WT/G701D, E522K/E522K, G701D/G701D, and E522K/
G701D fused with flag and HA epitope) were incubated as described
above using the mouse anti-HA antibody and rabbit anti-flag
polyclonal antibody. After they had been washed, the cells were
incubated with secondary antibody. The localization of fluorescently
labeled proteins was examined using confocal microscopy. Quanti-
tative analysis for immunofluorescence imaging was performed as
described elsewhere51 and in the legend of Figure 6b.
Cell surface biotinylation
The protocol of cell surface biotinylation was adapted from the
previous studies.15,33. Briefly, MDCK cells were co-transfected with
plasmids as described above. Parallel control cells were co-
transfected with vectors only (pcDNA3.1-HA and pCMV2.0-flag).
The cells were treated twice with 1 ml of 0.5 mg/ml EZ-Link
NHS-SS-biotin (Pierce Biotechnology, Rockford, IL, USA) in borate
buffer for 15 min at 4 1C. The cells were lysed with RIPA buffer.
After they had been washed, ImmunoPure (Pierce Biotechnology)
bead-bound protein was eluted by adding SDS sample buffer. The
content of kAE1 in the total bound and unbound fractions were
analyzed using immunoblotting with anti-HA antibody. The
scanning images were analyzed using NIH image software as
previously described.47,48
Protein stability analysis
MDCK cells, transfected with plasmids expressing kAE1 WT, E522K,
or G701D fused HA epitope, were incubated on 12-well tissue
culture plates for 24 h. At each time check point 0, 4, 7, and 11 h
after adding 25 mg/ml of cycloheximide (Calbiochem-Novabiochem
International, La Jolla, CA, USA), the cell lysates were separated
using SDS-PAGE, analyzed using immunoblotting with anti-HA and
anti-actin antibodies (as an internal control to standardize the
loading amount), and then analyzed using NIH image software as
previously described.47,48
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